高级检索
当前位置: 首页 > 详情页

Untargeted metabolomics combined with lipidomics revealed the effects of myocardial infarction and exercise rehabilitation on blood circulation metabolism of patients based on liquid chromatography-mass spectrometry

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Faculty of Food Science and Engineering, Kunming University of Science and Technology, Kunming, 650500, China. [2]Faculty of Chemical Engineering, Kunming University of Science and Technology, Kunming, 650500, China [3]Department of Cardiology, First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, 650000, China.
出处:
ISSN:

关键词: Etabolomics Lipidomics Myocardial infarction Exercise rehabilitation LC-MS

摘要:
Myocardial infarction (MI) is a major cause of death worldwide. Exercise rehabilitation (ER) is a powerful tool to improve life quality and prognosis of MI patients. Herein, we developed an untargeted metabolomics combined with lipidomics method to qualitatively and quantitatively detect metabolites in plasma. A total of 475 metabolites were annotated according to MS, MS/MS, and quantified by internal standard method. Moreover, medical statistical methods combined with chemometrics were used for metabolomics data mining and interpretation of clinical issues (matched Cohort 1, n = 90, Cohort 2, n = 6). The results illustrated that abnormal lipid metabolism is the most significant metabolic disorder for MI patients. And, three metabolic pathways, bile secretion, HIF-1 signaling pathway, and glutathione metabolism were uncovered in MI patients. Furthermore, glutamine, Phenylacetylglutamine (PAGln) and lysophosphatidylcholine (LPCs) were revealed as the essential biomarkers for ER of MI patients. Our findings revealed the metabolic landscape of MI and metabolic alterations after ER, will underlay potential applications of plasma metabolites in the detection of MI and optimization of ER program.Copyright © 2024 Elsevier B.V. All rights reserved.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
最新[2023]版:
大类 | 3 区 医学
小类 | 2 区 分析化学 3 区 药学
JCR分区:
出版当年[2024]版:
最新[2023]版:
Q2 CHEMISTRY, ANALYTICAL Q2 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2024版] 出版当年五年平均 出版前一年[2023版]

第一作者:
第一作者机构: [1]Faculty of Food Science and Engineering, Kunming University of Science and Technology, Kunming, 650500, China.
通讯作者:
通讯机构: [1]Faculty of Food Science and Engineering, Kunming University of Science and Technology, Kunming, 650500, China. [2]Faculty of Chemical Engineering, Kunming University of Science and Technology, Kunming, 650500, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:86907 今日访问量:1 总访问量:707 更新日期:2025-03-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号